Replies to post #126408 on Biotech Values

[ghmm]

I like reading the analysts report but they are often not how I would analyze the company and they also seem to fudge numbers to suit their needs. I always find it interesting how one company gets a high PE and another doesn't and why one dicount rate is used in one case and a higher in another... I am sure there is good reason for it :-).

One things odd was how they get they rating of "out perform", "market perform" and "under perform". Only looked at a couple but "Array" is listed as market perform and a target of $3. So they think Biotechs are going to go up 50% :-)!